TuHURA BIOSCIENCES, INC./NV Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number
TuHURA BIOSCIENCES, INC./NV (HURA) reported Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number of 280.00 thousand shares for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-28.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber · last filed 2021-09-28
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2021-06-30 was 0.00 shares.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, accelerated vesting, number for the quarter ending 2021-03-31 was 325.00 shares.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, accelerated vesting, number for fiscal 2021 was 280.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number 12 month |
|---|---|---|---|---|
| 2021-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | 325.00 shares derived: sum of 2 quarters · filed 2021-09-28 | 280.00K shares 10-K · filed 2021-09-28 | |
| 2021-03-31 | 325.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | 280.00K shares 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | 279.68K shares 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |